A B S T R A C T Parathyroid hormone increased basal adenyl cyclase activity and that increase was inhibited by prostaglandin El (PGE1). Tissue cyclic 3',5'-adenosine monophosphate (cyclic AMP) concentrations were increased by parathyroid hormone and that increase was likewise inhibited by PGE1. Both parathyroid hormone and dibutyryl cyclic AMP increased 'P incorporation into renal cortical phospholipids. PGE1 diminished the effect of parathyroid hormone but not dibutyryl cyclic AMP to influence that parameter. PGEl likewise modulated the effect of parathyroid hormone but not dibutyryl cyclic AMP to decrease fractional phosphate reabsorption by the renal tubule. It is suggested that PGE1 inhibits the effect of parathyroid hormone by decreasing its effect on adenyl cyclase. Such interaction may be important in modulating the intracellular action of parathyroid hormone on kidney cortex.
INTRODUCTION
Prostaglandins inhibit several hormonal actions mediated by cyclic 3',5'-adenosine monophosphate (cyclic AMP)' (1) (2) (3) (4) (5) (6) by interfering with the generation of that cyclic nucleotide (1) (2) (3) (4) (5) (6) (7) (8) . In addition, local release of prostaglandins in response to hormonal stimulation has been described in various tissues (9) (10) (11) . In adipose tissue, catecholamine stimulation in vitro has been reported to result in release of a sufficient amount of prostaglandins to inhibit the cyclic AMP-mediated lipolytic action of the catecholamines (11) . These observations and the known ubiquitous distribution of prostaglandins (1) led to the proposal that they might participate in an important local physiologic regulating mechanism functioning to modulate hormonal actions mediated by the adenyl cyclase-cyclic AMP system (5, 7, 11) .
Subsequent data indicated, however, that in certain tissues, prostaglandins themselves enhanced cyclic AMP generation (12) , mimicked the biologic action of effector hormone (13) , or appeared to have no significant interaction with the effector hormone (14) . Further, the responses observed varied with different prostaglandins. These results indicated that the effects of prostaglandins were dependent upon the particular prostaglandin, tissue, and hormonal action examined.
Several renal responses to the prostaglandins have been described (4, 6, 15, 16) . These include the observations that prostaglandin E1 (PGE1) inhibits the actions of vasopressin to (a) increase water permeability in isolated collecting ducts of rabbits (4); (b) increase renal medullary cyclic AMP levels (6); and (c) induce antidiuresis (16) . Additionally, PGE1 itself increases cyclic AMP concentration in the outer medulla (6) . Considerable data has accumulated to suggest that the physiologic actions of parathyroid hormone (PTH) on the renal cortex, like those of vasopressin on the renal medulla (17) , are mediated by PTH activation of the adenyl cyclase-cyclic AMP system (18) (19) (20) (21) (22) (23) (24) . In the present study we investigated the -interaction between PTH and PGEl on several renal cortical responses to PTH. The parameters examined were the effect PGE1 on (a) PTH (25) . The mixtures were incubated for 15 min at 370C, and then the reaction was terminated by boiling for 3 min. Cyclic AMP-14C was then extracted and assayed as described by Krishna, Weiss, and Brodie (26) .
For determination of cyclic AMP concentration, renal cortex was sliced to a thickness of less than 0.5 mm and a weight of 40-70 mg. The slices were incubated in KrebsRinger bicarbonate buffer (KRBB), pH 7.4, containing 10 mM theophylline, 200 mg bovine albumin/100 ml, 50 mg glucose/100 ml, and the study hormones as indicated in the results. The slices were incubated at 370C. After 15 min incubation, the slices were homogenized in 5% trichloroacetic acid and centrifuged at 700 g. Cyclic AMP was then extracted and assayed using the method (27) Phosphate excretion was studied. Eight mongrel dogs weighing 10-20 kg were anesthetized with sodium pentobarbital (30 mg/kg) intravenously and maintained with 25-mg doses as necessary. Through abdominal and flank incisions, both ureters and the left renal artery were catheterized. Isotonic sodium chloride infusions were begun into the left renal artery (0.1 ml/min) and the right jugular vein (1.7 ml/min). An inulin prime (50 mg/kg) was administered into the left jugular vein and a sustaining infusion of 25 mg/ml per min was then initiated. After a 30 min stabilization period, three 1 5-min control urines were collected separately from each ureter (collection period I), blood was sampled at the midpoint of each 15 min urine collection from a femoral vein. An infusion of PGE1 in 0.85% sodium chloride, 1.0 ug/0.1 ml per min, was then begun into the left renal artery and three additional 15-min urine collections and blood samples were obtained (period II). An infusion of PTH, 0.1 U/kg per min, was subsequently started via the right jugular vein at the same infusion rate as the saline control. Urines and blood samples were collected as described above (period III).
In six additional dogs a similar experimental protocol was employed to evaluate possible DBC and PGE, interaction. In this case, DBC, 20 gig/kg per min, was infused for 45 min into the right jugular vein.
Blood and urine samples were analyzed for inulin (29) and phosphorus (30) . Mean values for inulin clearance (CIN) and per cent tubular reabsorption of phosphate (per cent TRP) were calculated separately for each kidney over each total 45 min control and experimental collection period. Mean values from the right kidney were statistically compared with those from the corresponding collection period on the left. In addition the various collection periods in the same kidney were compared with each other using t test for paired values.
Different animal models were utilized in these studies for technical reasons. A larger number of slices from each kidney was necessary for the 'P incorporation into phospholipid experiments. Accordingly, the dog was chosen over the rat. Likewise, the design for evaluating PTH-PGE, interaction in vivo required a large animal. However, in a small series (n = 4) PTH increased cyclic AMP concentration from 5.2±SEM 1.3 to 14.9±0.9 in slices of dog renal cortex. The addition of PGE1 10M to the PTH 10 U/ml decreased the value to 6.2±0.1. These results indicate that the use of two models introduces no particular problem in interpretation of the results. RESULTS Adenyl cyclase activity. As shown in Fig. 1 , preliminary investigation indicated that a dose-response relationship existed between PTH concentration and adenyl cyclase activity. PTH 1 U/ml was found to be a submaximal dose. In further studies (Table I) , mean control adenyl cyclase activity of the renal cortex was 28± SE 2.0 pmoles cyclic AMP/mg protein per 15 min. PTH, 150 134 -12 (6) 0oo0-50 71 -7 (6) 29 -3(6) 5 10 PT H U/mI FIGURE 1 Response of renal cortical adenyl cyclase of the rat to parathyroid extract (PTE). A significant increase over basal adenyl cyclase, expressed as pmoles of cyclic AMP/mg protein per 15 min, occurred in response to 1 U/ml of PTE. PTE, 10 U/ml, did not increase adenyl cyclase significantly over the activity observed with 5 U/ml of PTE. Values for adenyl cyclase shown are mean ±SE. Numbers in parentheses give the size of each experimental population. mean adenyl cyclase activity was 29±2, a significant reduction from the value observed with PTH alone (42± 5), P < 0.02. PGEi, 10M, had no effect on PTH-induced increases in adenyl cyclase activity.
Cyclic AMP concentration. PTH, 10 U/ml, was found to be the lowest concentration to increase cyclic AMP concentration of rat renal cortical slices. This concentration of PTH increased cyclic AMP levels from a mean control value of 4.1±SE 0.6 nmoles cyclic AMP/g of wet tissue to 7.6+0.7, P < 0.01 (Table II) . PGE1 10EM alone had no effect on cyclic AMP concentration, mean 4.4± 0.7. However, when PTH, 10 U/mnl, was combined with PGE1 10M cyclic AMP concentration, 4.9+0.5 was significantly lower than the level observed with PTH alone (7.6±0.7), P < 0.01. PGE1 10-7M had no effect on PTH-induced increases in cyclic AMP concentration. 'P incorporation into phospholipids. PTH, 3 U/ml, significantly increased 3P incorporation into phospholipids by canine renal cortical slices (Table III) , mean increase from basal values 100.3±SEMD 18.1 cpm/mg wet tissue per 120 min, P < 0.0005. '8P incorporation was also significantly increased by DBC, 500 mg/ml, mean kidney to be less than that on the right. Mean difference (right-left kidney) in reduction of per cent TRP in response to PTH was -4.0%±1.1. Although small, this difference in responsiveness was statistically significant, P < 0.025. No significant changes in mean CIN were observed in either kidney during the collection periods. A phosphaturic action of intravenously infused DBC, 20 sLg/kg per min, was also observed (Fig. 3, Table IV ). This action of DBC has been previously described (23, 
DISCUSSION
The results indicate that PGE1 inhibits the effect of submaximal doses of PTH to activate adenyl cyclase and increase intracellular cyclic AMP concentration in rat renal cortical tissue in vitro. The doses of PGE1 effective in antagonizing these actions of PTH did not alone influence renal cortical adenyl cyclase activity or cyclic AMP concentration. In view of the differences in the assay systems, little biologic significance can probably be attached to the different concentrations of PTH and PGE1 employed in the study of these two parameters. These in vitro systems also required relatively high concentrations of PGE1, 1OM in the homogenates, and lOM in the slices, to demonstrate an effect. PTH activation of renal cortical adenyl cyclase-cyclic AMP system is well documented (20, 21) , with hormone-sensitive adenyl cyclase found predominantely in the plasma membrane fraction (20) . In view of the present results, it is possible that PGE1 at these concentrations might interfere with PTH activation of the adenyl cyclase-cyclic AMP system by competing with the hormone for specific membrane receptor sites at the surfaces of the cell. A similar mechanism has been proposed for PGE1 inhibition of the action of vasopressin to increase water permeability (3, 4, 6) and that of catecholamines to stimulate lipolysis in adipose tissue (7) . The influence of PGE1 on other renal cortical responses to PTH was also compatible with this hypothesis. It was demonstrated in vitro that PTH potentiated inorganic 'P incorporation into phospholipids in canine renal cortical slices. Enhanced incorporation of 8P into phospholipid in response to PTH had previously been reported using an in vivo model in which PTH was given intravenously to rats (31) . In the present study, DBC also potentiated :'P incorporation into phospholipids in vitro. Cyclic AMP mediation of this PTH action is thus suggested. PGE1 10WM, which alone had no significant effect on 'P incorporation, inhibited PTH but not DBC stimulation of this parameter. These results imply, therefore, that the antagonistic effect of PGE1 on this action of PTH occurs at some point before hormonal stimulation of cyclic AMP generation and are consistent with the previously observed PGE1 interference with adenyl cyclase activation.
The physiologic significance of PTH potentiation of 82p incorporation into phospholipids is unclear. PTH stimulation of this parameter in intestine and bone as well as kidney suggest it may be a rather generalized response of PTH-sensitive tissues (32, 33) . In addition, increased 'P incorporation into phospholipids has been observed in other target tissues in response to other hormones (34) (35) (36) . Cyclic AMP is also thought to mediate the phosphaturic action of PTH (23, 24) . Therefore, a possible interaction between PTH and PGE1 was sought in vivo.
In order to compare the renal effects of PTH alone and PGE1 and PTH together, experiments were designed to limit the effect of PGE1 to one (the left) kidney. The design was tested in each experiment by comparing renal function in both kidneys when only the diluent was infused ( In the kidney selectively perfused with PGEi, a small but statistically significant decrease in responsiveness to PTH was observed relative to the opposite control kidney as reflected by a decrease in the magnitude of PTH-induced inhibition of tubular phosphate reabsorption in the PGEi-perfused kidney. An inhibitory effect of PGE1 on the phosphaturic action of DBC was not seen. Therefore, qualitatively the interaction between PGE1, PTH, and DBC in vivo appeared to be similar to that demonstrated in vitro. Since increase in glomerular filtration rate have previously been reported in response to the commercial PTH extract employed in this study (37) , per cent TRP was employed as an index of tubular phosphate transport to negate the influence of this variable on phosphate excretion. Significant changes in mean CIN during different collection periods of a given experiment were not, however, noted in the present study, perhaps due to the lower total dose and slower rat of administration of PTH employed (37) .
The effect of PGEi on PTH inhibition of tubular phosphate reabsorption was small. The physiologic importance of this interaction, therefore, remains uncertain. It is of interest in this regard that the magnitude of the phosphaturic response to PTH was reduced in the PGEi-infused kidney despite the fact that PGE1 infusion alone appeared to decrease per cent TRP. The explanation for this apparent inhibitory effect of PGE1 on renal tubular phosphate reabsorption is unclear. A correlation between decreased proximal tubule sodium and phosphate reabsorption has recently been reported (24) . The phosphaturic action of PGE1 observed here could possibly be related to its natriuretic action (15) . An independent effect of PGEi to decrease proximal tubular sodium (and phosphate) reabsorption might thus diminish its net inhibitory action on PTH-induced phosphaturia. Such a mechanism is speculative but deserves further study since it could explain the small in vivo effect of PGE, on PTH phosphaturic action compared with the more apparent in vitro interaction.
In summary, the data indicate that PGEi is able to modify several renal responses to PTH. This effect of PGE1 would appear to depend upon its interference with PTH activation of sensitive renal cortical adenyl cyclase, inhibiting hormone-induced cyclic AMP generation and cyclic AMP-mediated hormonal actions. PGE1 and perhaps other prostaglandins might, therefore, participate in an important local negative feedback system modulating the renal actions of PTH. Such a homeostatic mechanism would probably require local release of prostaglandins by the renal cortex in response to PTH stimulation in amounts sufficient to inhibit PTH action (10) .
Such local release of prostaglandins in the renal cortex has not been demonstrated. For this and other reasons discussed, the physiologic importance of the observed interaction between PGE1 and PTH remains speculative.
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